Johnson & Johnson MedTech announced today that the FDA cleared its Monarch Quest technology for robotic-assisted bronchoscopy ...

Johnson & Johnson MedTech (NYSE: JNJ) announced new regulatory nods for multiple orthopedic technology offerings.

Johnson & Johnson MedTech said Wednesday its Monarch Quest robotic platform received clearance from the Food and Drug ...

JNJ's $14B acquisition of ITCI bolsters its portfolio with Caplyta, showing strong sales and patent protection until 2033.

A depression drug candidate that’s a key part of Johnson & Johnson’s neuroscience strategy has failed a Phase 3 clinical trial, the latest dose of disappointing news for an emerging class of ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Dr. Marty Makary, President Donald Trump's choice to lead the Food and Drug Administration, pointed out the Biden ...

Johnson & Johnson recently announced the appointment ... robust product-related announcements like FDA approvals and encouraging clinical trial results, and notable earnings reports showing ...

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other psychedelic ...

Johnson, now 69, was facing life in prison without the possibility of parole for being a first-time nonviolent drug offender.

Bryan Johnson, 47, made his fortune after selling his payment processing company Braintree to PayPal for $800 million in cash ...